Global technology powerhouse Siemens said its Egypt unit has appointed Dalia Shoukry as the new chief financial officer.
Shoukry has over two decades of experience in corporate finance in the pharmaceutical industry.
Prior to Siemens, she was AstraZenecas international finance director, and previously held senior financial roles based in Egypt, the UK and France with responsibilities spanning Europe, the Middle East and Africa at AstraZeneca and Bristol Myers Squibb. She earned a degree in accounting from Ain Shams University.
Lauding the appointment, Siemens Egypt CEO Mostafa El Bagoury said: "We are very happy to welcome Shoukry to our team in Egypt. Financing is a crucial component of our business, as it not only defines, manages, and oversees all budgets, but it also monitors the performance and ensures the financial health and stability of Siemens Egypt."
"We wish Shoukry great success in supporting us, our customers and the country as Egypt continues its digitalization and development journey," he added.
Siemens has been active in Egypt ever since its founder, Werner von Siemens, laid a communications cable through the Red Sea in 1859 to link Suez and Aden. In 1901 Siemens opened its first office in Cairo and since then, the company has been a key contributor to critical infrastructure in Egypt.
On her appointment, Shoukry said: "This is an exciting time to join a technology company thats deeply involved in the digitalization of infrastructure and industry, which is at the core of Egypts major development projects."
"I look forward to providing Siemens and our customers with the appropriate financing arrangements and processes that will turn these ambitious visions into a reality," he added.
Copyright 2021 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
